Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Anaemia | x | |||
Anorexia | x | |||
Ataxia | x | x | ||
Neoplasm malignant | x | x | ||
Dizziness | x | x | ||
Fatigue | x | |||
Leukopenia | x | x | ||
Nausea | x | x | ||
Neoplasm | x | x | ||
Neuropathy peripheral | x | x | ||
Convulsion | x | |||
Thrombocytopenia | x | x | ||
Vertigo | x | x | ||
Vomiting | x | x | ||
Peripheral sensory neuropathy | x | |||
Phosphatase alkaline increased | x | |||
Neurological symptom | x | x | ||
Neurotoxicity | x | x | ||
Affective disorder | x | x | ||
Myelosuppression | x | x | ||
Ovarian cancer | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |